Aquaporin A/S Sets Date for Extraordinary General Meeting
Aquaporin A/S, a leader in water filtration technology, is gearing up for an extraordinary general meeting to be held soon.
Meeting Overview
The meeting will take place on December 1, 2025, at 16:30 (CET) at the company’s main office. The primary goal is to discuss essential company proposals aimed at raising capital to support future growth strategies.
Agenda Highlights
During the general meeting, several key proposals will be presented to the shareholders. These proposals are focused on the flexibility required to access funding, estimated to be between DKK 125 million to DKK 175 million, which will facilitate the company’s ongoing operational needs.
Proposed Amendments to Articles of Association
- The first proposal involves a revision allowing the Board of Directors to increase the share capital with pre-emptive rights for existing shareholders at a potential discount to market price.
- The second proposal seeks an amendment that permits capital increases without pre-emptive rights at or above market value.
- The third proposal requests authorization for share capital increases without pre-emptive rights at a price which may be below market price, specifically benefiting external parties.
- The final proposal aims to combine the prior authorizations to enable maximum efficiency in capital raising efforts.
Requirements for Participation
To take part in the meeting, shareholders must confirm their attendance by November 27, 2025. This confirmation ensures everyone can participate in the critical discussions that will shape the future of Aquaporin.
Company Insights and Future Prospects
Aquaporin is renowned for its innovative water technologies that leverage biotechnology for efficient water filtration. The company has successfully integrated components from biology, chemistry, and physics into its unique Aquaporin Inside technology. This groundbreaking approach addresses global water challenges across various industries. From NASA missions to residential water purification, Aquaporin's solutions are transforming how water is managed and accessed.
With a presence in Denmark, Singapore, Turkey, the United States, and China, Aquaporin aims to create long-lasting partnerships and projects that enhance drinking water quality, treat industrial wastewater, and concentrate food products sustainably.
For Further Information
The leadership team, including the Chief Executive Officer Ulrik Lund Jakobsen and Chief Financial Officer Klaus Juhl Wulff, is available for inquiries. They encourage dialogue regarding the upcoming meeting and the company’s strategic direction, underscoring the importance of community and shareholder involvement.
Frequently Asked Questions
What is the purpose of the extraordinary general meeting?
The meeting aims to present and discuss proposals to raise capital for Aquaporin's growth and operational needs.
When will the meeting take place?
The extraordinary general meeting is scheduled for December 1, 2025, at 16:30 (CET).
How can shareholders participate in the meeting?
Shareholders must notify Aquaporin of their attendance by November 27, 2025, to participate in the discussions.
What proposals will be discussed at the meeting?
Key proposals include amendments to the Articles of Association regarding share capital increases with and without pre-emptive rights.
Who can I contact for more information?
For inquiries, you can reach out to CEO Ulrik Lund Jakobsen or CFO Klaus Juhl Wulff directly through official communication channels.
